Paper19200802
Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells.
Somervaille TC and 9 others. Cell Stem Cell, 2009. Cited by 308 papers, by iCite.
Cite this record
ConductScience Library. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Papers, record 19200802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19200802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Embryonic Stem Cells | Major topic |
| Myeloid-Lymphoid Leukemia Protein | Major topic |
| Neoplastic Stem Cells | Major topic |
| Transcription, Genetic | Major topic |
| Animals | |
| Cells, Cultured | |
| Chromobox Protein Homolog 5 | |
| Chromosomal Proteins, Non-Histone | |
| Disease Models, Animal | |
| Gene Expression Profiling | |
| Gene Expression Regulation, Leukemic | |
| HMGB3 Protein | |
| Humans | |
| Mice | |
| Mice, Inbred C57BL | |
| Oligonucleotide Array Sequence Analysis | |
| Oncogene Proteins v-myb | |
| Oncogene Proteins, Fusion |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 CA009151 | NCI NIH HHS | United States | T32CA009151 | PubMed and NIH | NIH RePORTER |
| R01 CA116606 | NCI NIH HHS | United States | R01CA116606 | PubMed and NIH | NIH RePORTER |
| C147/A6058 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| CA 116606 | NCI NIH HHS | United States | R01CA116606 | PubMed and NIH | NIH RePORTER |
| CA 55029 | NCI NIH HHS | United States | R01CA055029 | PubMed and NIH | NIH RePORTER |
| R01 CA055029 | NCI NIH HHS | United States | R01CA055029 | PubMed and NIH | NIH RePORTER |
| T32 CA 09151 | NCI NIH HHS | United States | T32CA009151 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 19200795 | The MLLgnant consequences of reverting to an embryonic transcriptional program. | https://conductscience.org/library/papers/19200795 |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16507773 | c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. | Blood | 2006 | https://conductscience.org/library/papers/16507773 | PubMed |
| 2 | 12952893 | Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. | Genes Dev | 2003 | https://conductscience.org/library/papers/12952893 | PubMed |
| 3 | 16990388 | Cancer stem cells. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16990388 | PubMed |
| 4 | 18079385 | Comment on "Tumor growth need not be driven by rare cancer stem cells". | Science | 2007 | https://conductscience.org/library/papers/18079385 | PubMed |
| 5 | 17045204 | Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. | Cancer Cell | 2006 | https://conductscience.org/library/papers/17045204 | PubMed |
| 6 | 12714970 | Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. | Nature | 2003 | https://conductscience.org/library/papers/12714970 | PubMed |
| 7 | 18397753 | Module map of stem cell genes guides creation of epithelial cancer stem cells. | Cell Stem Cell | 2008 | https://conductscience.org/library/papers/18397753 | PubMed |
| 8 | 11242054 | Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. | Nature | 2001 | https://conductscience.org/library/papers/11242054 | PubMed |
| 9 | 12620410 | MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. | Cancer Cell | 2003 | https://conductscience.org/library/papers/12620410 | PubMed |
| 10 | 16199517 | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16199517 | PubMed |
| 11 | 11986236 | The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. | Blood | 2002 | https://conductscience.org/library/papers/11986236 | PubMed |
| 12 | 18443585 | An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. | Nat Genet | 2008 | https://conductscience.org/library/papers/18443585 | PubMed |
| 13 | 11134512 | Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11134512 | PubMed |
| 14 | 15070702 | Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. | Blood | 2004 | https://conductscience.org/library/papers/15070702 | PubMed |
| 15 | 12070033 | Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. | Blood | 2002 | https://conductscience.org/library/papers/12070033 | PubMed |
| 16 | 9353180 | Oncogenic transcription factors in the human acute leukemias. | Science | 1997 | https://conductscience.org/library/papers/9353180 | PubMed |
| 17 | 17906700 | Leukaemia lineage specification caused by cell-specific Mll-Enl translocations. | Oncogene | 2008 | https://conductscience.org/library/papers/17906700 | PubMed |
| 18 | 18523148 | Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. | Blood | 2008 | https://conductscience.org/library/papers/18523148 | PubMed |
| 19 | 67373 | Colony assay for proliferative blast cells circulating in myeloblastic leukaemia. | Lancet | 1977 | https://conductscience.org/library/papers/67373 | PubMed |
| 20 | 12738660 | Identification of a gene expression signature associated with pediatric AML prognosis. | Blood | 2003 | https://conductscience.org/library/papers/12738660 | PubMed |
Cited by227
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 308 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42913019 | Polycomb factor PHF19 affects AML initiation, patient prognosis, and survival. | Sci Adv | 2026 | https://conductscience.org/library/papers/42913019 | PubMed |
| 42840520 | Interplay between epigenetics and metabolism controls cancer stem cell plasticity. | Front Epigenet Epigenom | 2024 | https://conductscience.org/library/papers/42840520 | PubMed |
| 42794935 | Increasing H3K9 Methylation Level Reduces the Proliferation of Leukemic Stem Cells. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794935 | PubMed |
| 42090509 | TCF3::HLF orchestrates an enhancer-promoter network with activation of MEF2C to promote immature HSC gene expression in leukemia. | Sci Adv | 2026 | https://conductscience.org/library/papers/42090509 | PubMed |
| 41882099 | A Perturb-seq map of a differentiation hub reveals synergistic vulnerabilities in KMT2A-rearranged acute myeloid leukemia. | Leukemia | 2026 | https://conductscience.org/library/papers/41882099 | PubMed |
| 40921261 | KMT2A-rearranged leukemia: from mechanism to drug development. | Exp Hematol | 2025 | https://conductscience.org/library/papers/40921261 | PubMed |
| 40744921 | Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40744921 | PubMed |
| 40374809 | The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms. | Leukemia | 2025 | https://conductscience.org/library/papers/40374809 | PubMed |
| 40294241 | Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation. | Blood Cancer Discov | 2025 | https://conductscience.org/library/papers/40294241 | PubMed |
| 40240608 | Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation. | Nature | 2025 | https://conductscience.org/library/papers/40240608 | PubMed |
| 40180954 | Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance. | Nat Commun | 2025 | https://conductscience.org/library/papers/40180954 | PubMed |
| 40102405 | Guanine nucleotide biosynthesis blockade impairs MLL complex formation and sensitizes leukemias to menin inhibition. | Nat Commun | 2025 | https://conductscience.org/library/papers/40102405 | PubMed |
| 39062899 | Structure and Functions of HMGB3 Protein. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39062899 | PubMed |
| 39017851 | MYB as a Critical Transcription Factor and Potential Therapeutic Target in AML. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/39017851 | PubMed |
| 39004675 | PHF6 suppresses self-renewal of leukemic stem cells in AML. | Leukemia | 2024 | https://conductscience.org/library/papers/39004675 | PubMed |
| 38607055 | Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection. | Cells | 2024 | https://conductscience.org/library/papers/38607055 | PubMed |
| 38601080 | Aberrant stem cell and developmental programs in pediatric leukemia. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/38601080 | PubMed |
| 38542205 | Transcription Factor MYB as Therapeutic Target: Current Developments. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38542205 | PubMed |
| 38413714 | Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. | Nat Cancer | 2024 | https://conductscience.org/library/papers/38413714 | PubMed |
| 38271660 | PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway. | Blood | 2024 | https://conductscience.org/library/papers/38271660 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19200802
GET https://conductscience.org/api/papers/v1/19200802/references?page=2